Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adrienne Farid Insider Profile
4 Followers
Adrienne Farid, COO at Century Therapeutics, holds 135.13K shares in Century Therapeutics (Ticker: IPSC). Most recently, Adrienne Farid Sold $1,033 shares of Century Therapeutics on Nov 05, 2024 for an estimated value of 1.26K.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+54.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
COO
Roles that Adrienne Farid holds in companies
Most Profitable Insider Trade
The most profitable trade made by Adrienne Farid
Adrienne Farid's Trading History
List of latest transactions for each holding click on a transaction to see Adrienne Farid's performance on stock
You May Also Like
Adrienne Farid insider profile FAQ
What is the percentage of profitable transactions made by Adrienne Farid?
The percentage of profitable transactions made by Adrienne Farid is 100%.
What is the average return per transaction made by Adrienne Farid?
The average return per transaction made by Adrienne Farid is 54.00%.
What stocks does Adrienne Farid hold?
Adrienne Farid holds: IPSC stocks.
What was Adrienne Farid’s latest transaction?
Adrienne Farid latest transaction was an Informative Sell of $1.26K.
What was Adrienne Farid's most profitable transaction?
Adrienne Farid’s most profitable transaction was an Informative Sell of IPSC stock on February 7, 2024. The return on the trade was 72.30%.
What is Adrienne Farid's role in Century Therapeutics?
Adrienne Farid's role in Century Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.